These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 29897466)

  • 1. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA.
    Zhou YF; Xiong YQ; Tao MT; Li L; Bu MX; Sun J; Liao XP; Liu YH
    J Antimicrob Chemother; 2018 Jul; 73(7):1899-1907. PubMed ID: 29897466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of linezolid resistance cfr gene among MRSA isolates.
    Wali M; Shah MS; Rehman TU; Wali H; Hussain M; Zaman L; Khan FU; Mangi AH
    J Infect Public Health; 2022 Oct; 15(10):1142-1146. PubMed ID: 36155853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a rifampicin pre-treatment on linezolid pharmacokinetics.
    Okazaki F; Tsuji Y; Seto Y; Ogami C; Yamamoto Y; To H
    PLoS One; 2019; 14(9):e0214037. PubMed ID: 31518346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of different linezolid susceptibility testing methods and detection of linezolid resistance gene (cfr) in staphylococcal isolates.
    Nandivarmane SB; Manoharan M; Sugumar M; Sistla S
    Indian J Med Microbiol; 2024; 47():100516. PubMed ID: 38000621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model.
    Kong D; Liu X; Li X; Hu J; Li X; Xiao J; Dai Y; He M; Liu X; Jiang Y; Cui R; Zhang L; Wang J; Li A; Wang F; Zhang Y; Xiao J; Wang W; Zheng C
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31484796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying exposure targets for treatment of staphylococcal pneumonia with ceftobiprole.
    Rodvold KA; Nicolau DP; Lodise TP; Khashab M; Noel GJ; Kahn JB; Gotfried M; Murray SA; Nicholson S; Laohavaleeson S; Tessier PR; Drusano GL
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3294-301. PubMed ID: 19451287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial pneumonia-induced shedding of epithelial heparan sulfate inhibits the bactericidal activity of cathelicidin in a murine model.
    Zehr EP; Erzen CL; Oshima K; Langouet-Astrie CJ; LaRiviere WB; Shi D; Zhang F; McCollister BD; Windham SL; Rizzo AN; Bastarache JA; Horswill AR; Schmidt EP; Kwiecinski JM; Colbert JF
    Am J Physiol Lung Cell Mol Physiol; 2024 Feb; 326(2):L206-L212. PubMed ID: 38113313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifampicin reduces plasma concentration of linezolid in patients with infective endocarditis.
    Bock M; Van Hasselt JGC; Schwartz F; Wang H; Høiby N; Fuursted K; Ihlemann N; Gill S; Christiansen U; Bruun NE; Elming H; Povlsen JA; Køber L; Høfsten DE; Fosbøl EL; Pries-Heje MM; Christensen JJ; Rosenvinge FS; Torp-Pedersen C; Helweg-Larsen J; Tønder N; Iversen K; Bundgaard H; Moser C
    J Antimicrob Chemother; 2023 Dec; 78(12):2840-2848. PubMed ID: 37823408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual meropenem epithelial lining fluid and plasma PK/PD target attainment.
    Rohani R; Yarnold PR; Scheetz MH; Neely MN; Kang M; Donnelly HK; Dedicatoria K; Nozick SH; Medernach RL; Hauser AR; Ozer EA; Diaz E; Misharin AV; Wunderink RG; Rhodes NJ
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0072723. PubMed ID: 37975660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the impact of rifampicin on the plasma concentration of linezolid in tuberculosis co-infected patients.
    Yan P; Shi QZ; Hu YX; Zeng Y; Lu H
    Front Pharmacol; 2023; 14():1260535. PubMed ID: 38026932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dose adjustment of linezolid due to interacction with rifampicin in infective endocarditis].
    Puplà Bartoll A; Bellés Medall MD; Pérez Catalán IE; Roig Martí C; Bodega Azuara J; Gil Candel M; Esteve López V; Ferrando Piqueres R
    Rev Esp Quimioter; 2023 Aug; 36(4):436-438. PubMed ID: 37116051
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis.
    Li Y; Lei G; Dong W; Lan T; Fan J; Qin S
    BMC Infect Dis; 2024 Jan; 24(1):50. PubMed ID: 38182990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review.
    Xu Q; Sang Y; Gao A; Li L
    Eur J Clin Pharmacol; 2024 Jun; 80(6):785-795. PubMed ID: 38421436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "External evaluation of the predictive performance of published population pharmacokinetic models of linezolid in adult patients" [Journal of Global Antimicrobial Resistance 35 (2023) 347-353].
    Qin Y; Jiao Z; Ye YR; Shen Y; Chen Z; Chen YT; Li XY; Lv QZ
    J Glob Antimicrob Resist; 2024 Mar; 36():492. PubMed ID: 38521549
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment strategies for persistent methicillin-resistant Staphylococcus aureus bacteraemia.
    Lewis PO; Heil EL; Covert KL; Cluck DB
    J Clin Pharm Ther; 2018 Oct; 43(5):614-625. PubMed ID: 30003555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine Protease-Mediated Autocleavage of
    Zhang Y; Li S; Yang Z; Shi L; Yu H; Salerno-Goncalves R; Saint Fleur A; Feng H
    Cell Mol Gastroenterol Hepatol; 2018; 5(4):611-625. PubMed ID: 29930981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin or linezolid empiric MRSA coverage with potential ventilator-associated pneumonia has no benefit or effect on outcomes: antibiotic stewardship implications.
    Cunha BA; Jaber N; Blum S
    Int J Antimicrob Agents; 2018 Nov; 52(5):733-734. PubMed ID: 29909171
    [No Abstract]   [Full Text] [Related]  

  • 18. Bleeding interaction between fluconazole and warfarin.
    de Filette J; Michiels V
    Lancet; 2018 Sep; 392(10153):e9. PubMed ID: 30303086
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Fluconazole on the Pharmacokinetic Properties of Imrecoxib, a Novel NSAID: A Single-center, Open-label, Self-controlled Study in Healthy Chinese Male Volunteers.
    Zuo CZ; Gong Y; Hou XY; Zhang YF; Peng WX; Zhu RH; Zhong DF; Chen XY
    Clin Ther; 2018 Aug; 40(8):1347-1356. PubMed ID: 30017171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Fluconazole and Itraconazole on the Pharmacokinetics of Erdafitinib in Healthy Adults: A Randomized, Open-Label, Drug-Drug Interaction Study.
    Poggesi I; Li LY; Jiao J; Hellemans P; Rasschaert F; de Zwart L; Snoeys J; De Meulder M; Mamidi RNVS; Ouellet D
    Eur J Drug Metab Pharmacokinet; 2020 Feb; 45(1):101-111. PubMed ID: 31673875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.